Home
Conditions
Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis

Clinical trial condition

Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis

Explore clinical trials studying Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis. Study availability and eligibility vary by location and protocol.

21 public trials 10 recruiting studies

Refine in advanced search Browse all conditions

Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis trial results

Recruiting

Safety and Efficacy of Tarperprumig in Adult Participants With Anti-Neutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis

NCT07160608

Conditions: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis, Autoimmune Diseases, +8 more
Locations: Research Site Ciudad de Buenos Aires, Argentina

Research Site Ciudad de Buenos Aires, Argentina

Research Site La Plata, Argentina

Research Site Rosario, Argentina

View all 78 locations

View Trial Details

Recruiting

Study of Salvage Therapy to Treat Patients With Granulomatosis With Polyangiitis

NCT04871191

Conditions: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis, Autoimmune Diseases, +13 more
Locations: Hôpital de la Croix Saint Simon Paris, France

View Trial Details

Recruiting

An Exploratory Clinical Study of YTS109 Cell for R/R Autoimmune Diseases

NCT07236762

Conditions: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis, Antiphospholipid Syndrome, +40 more
Locations: The third people's Hospital of Bengbu Bengbu, China

View Trial Details

Recruiting

A Clinical Study of YTS109 Cells for the Treatment of R/R Autoimmune Diseases

NCT07123519

Conditions: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis, Antiphospholipid Syndrome, +34 more
Locations: Institute of Hematology & Blood Diseases Hospital, China Tianjin, China

View Trial Details

Recruiting

A Clinical Study of YTS109 Cell for R/R Autoimmune Diseases

NCT07104721

Conditions: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis, Antiphospholipid Syndrome, +35 more
Locations: The First Affiliated Hospital of Anhui Medical University Hefei, Anhui, China

View Trial Details

Recruiting

Exploratory Clinical Study on the Safety and Efficacy of Anti- CD19/BCMA U CAR-T Cell Injection for the Treatment of Relapsed/Refractory Autoimmune Diseases

NCT07246096

Conditions: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis, Arthritis, +20 more
Locations: Changhai Hospital Shanghai, China

View Trial Details

Recruiting

A Clinical Study of YTS109 Cell in R/R Autoimmune Diseases

NCT06978647

Conditions: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis, Antiphospholipid Syndrome, +29 more
Locations: The First Medical Center of Chinese PLA General Hospital Beijing, Beijing Municipality, China

View Trial Details

Recruiting

Fourth-gen CAR T Cells Targeting BCMA/CD19 for Refractory Systemic Lupus Erythematosus (SLE)

NCT06350110

Conditions: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis, Arthritis, +50 more
Locations: District One Hospital Beijing, Beijing Municipality, China

View Trial Details

Recruiting

An Clinical Study of YTS109 Cell Injection in Subjects With Recurrent/Refractory Autoimmune Disease

NCT06379646

Conditions: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis, Antiphospholipid Syndrome, +32 more
Locations: Shanghai Changzheng Hospital Shanghai, Shanghai Municipality, China

View Trial Details

Recruiting

Safety and Efficacy of CD19 Targeted CAR-T Therapy for Refractory Autoimmune Disease

NCT06056921

Conditions: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis, Arthritis, +32 more
Locations: Shanxi Bethune Hospital Taiyuan, Shanxi, China

View Trial Details

Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis

Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis trial results

Related conditions